Reports emerged regarding Donald Trump's health and potential use of power to obtain a drug, involving the White House and FDA.
2 reports, 2 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 5
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Reports emerged regarding Donald Trump's health and potential use of power to obtain a drug, involving the White House and FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A Cyclospora outbreak linked to iceberg lettuce in Morocco is prompting the FDA to suspend duties on imported fertilizer, amidst broader political pressures.Sub-event
The search for the FDA commissioner is underway, involving the White House and administration details.1 source
- Speculation links Donald Trump to issues regarding drug access.Sub-event
- President Trump blamed the medical and pharmaceutical industry for media scrutiny on August 10th.Sub-event
White House contacted regarding Trump's health; questions raised about drug acquisition.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- FDA
Related events
- FDA is reviewing a new sunscreen ingredient while NPR reports on Donald Trump's political tensions.
- Trump administration slashes food safety enforcement and reduces workforce at FDA, FSIS, and CDC.
- A report analyzes policy changes under the Trump administration affecting healthcare and Medicare.
- Trump announces a radical shift in drug policy, while the Secretary of State defends aggressive military action.
- Jonathan Reiner appeared on CNN as a medical analyst to critique the official health narrative regarding Donald Trump.